期刊文献+

β-arrestin1激活JNK信号通路促进慢性髓细胞白血病细胞K562增殖 被引量:3

β-arrestin1 promotes chronic myeloid leukemia cell proliferation by activating JNK signaling pathway
下载PDF
导出
摘要 目的以CML K562细胞为研究对象,探索β-arrestin1促进CML细胞增殖的相关信号通路。方法以β-arrestin1慢病毒载体感染CML K562细胞,形成稳定的K562-siβ1和K562-β1细胞,及非特异性si RNA对照K562-Ctrl细胞。以此为研究对象,利用细胞计数与CCK-8实验检测细胞增殖能力;Western blot检测蛋白表达;免疫共沉淀(Co-IP)实验检测蛋白间的相互作用。结果细胞计数与CCK-8实验结果显示K562-β1细胞增殖与细胞存活率能力显著高于K562-Ctrl,而K562-siβ1显著低于K562-Ctrl。Western blot结果表明β-arrestin1特异性增强磷酸化JNK表达,JNK抑制剂SP600125能抑制p-JNK表达和K562细胞增殖;免疫共沉淀实验表明β-arrestin1能与Src结合。结论 CML K562细胞中β-arrestin1与Src结合,促进JNK信号通路激活,从而促进细胞增殖。 Objective To investigate the signaling pathways involved inβ-arrestin1-induced proliferation of K562 cells. Methods We established stable cell lines K562-siβ1 and K562-β1 by lentivirus-mediated β-arrestin1 knock-down or overexpression in K562 cells, with cells transfected with non-specific siRNA as the control (K562-Ctrl). The proliferation of these cells were evaluated by cell counting and CCK-8 assays. Western blotting was used to detect the expression of JNK and p-JNK in the cells, and co-immunoprecipitation (Co-IP) assay was employed to investigate the interaction between β-arrestin1 and Src. Results K562-β1 cells showed significantly greater but K562-siβ1 cells had significantly lower proliferation ability and cell survival rate than K562-Ctrl cells. Western blotting showed thatβ-arrestin1 specifically enhanced the expression of p-JNK, and the JNK inhibitor SP600125 obviously suppressed p-JNK and cell proliferation of K562 cells. Co-IP assay revealed the binding ofβ-arrestin1 to Src. Conclusions In K562 cells,β-arrestin1 activates JNK signaling pathway by binding to Src to promote the cell proliferation.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2015年第5期677-681,共5页 Journal of Southern Medical University
基金 国家自然科学基金(81373444)~~
关键词 β-arrestin1 CML 细胞增殖 JNK β-arrestin1 chronic myelocytic leukemia cell proliferation JNK
  • 相关文献

参考文献24

  • 1Rowley JD. Letter: a new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining[J], Nature, 1973,243: 290-3.
  • 2Sinclair A, Latif AL, Holyoake TL. Targeting survival pathways in chronic myeloid leukaemia stem cells[J]. Br J Pharmacol, 2013, 169 (8): 1693-707.
  • 3Lefkowitz RJ, Whalen EJ. Beta-arrestins: traffic cops of cell signaling[J]. Curr Opin Cell Biol, 2004, 16(2): 162-8.
  • 4Goldberg AD, Allis CD, Bernstein E. Epigenetics: a landscape takes shape[J]. Cell, 2007, 128(4): 635-8.
  • 5Di W, Wu J. Involvement of b-arrestins in cancer progression [J]. Mol Biol Rep, 2013, 40(2): 1065-71.
  • 6Mcdonald PH, Chow CW, Miller WE, et al. beta-Arrestin 2: A receptor-regulated MAPK scaffold for the activation of JNK3 [J]. Science, 2000, 290(5496): 1574-7.
  • 7Luttrell LM, Roudabush FL, Choy EW, et al. Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds[J]. Proc Natl Acad Sci USA, 2001, 98(5): 2449-54.
  • 8Bruchas MR, Macey TA, Lowe JD, et al. Kappa opioid receptor activation of p38 MAPK is GRK3-and arrestin-dependent in neurons and astrocytes[J]. J Biol Chem, 2006, 281(26): 18081-9.
  • 9Li K, Qi X. b-Arrestinl promotes the progression ofchronic myeloid leukaemia by regulatingBCR/ABL H4 acetylation[J]. Br J Cancer, 2014, 111(3): 568-76.
  • 10Sasaki DT, Murray BW. SP600125,an anthrapyrazolone inhibitor of Jun N-terminal kinase[J]. Proc Natl Acad Sci USA, 2001, 98(24): 13681-6.

二级参考文献10

  • 1Nobles KN, Guan Z, Xiao K, et al. The active conformation of betaarresfinl: direct evidence for the phosphate sensor in the N-domain and eonformational differences in the active state of beta-arrestinl and-2[J]. J Biol Chem, 2007, 282(29): 21370-21381.
  • 2Yu MC, Su LL, Zou L, et al. An essential function for beta-arrestin2 in the inhibitory signaling of natural killer cells[J]. Nat Immunol, 2008, 9(8): 898-907.
  • 3Matsubayashi J, Takanashl M, Oikawa K, et al. Expression of G protein-coupled receptor kinase 4 is associated with breast cancer tumourigenesis[J]. J Pathol, 2008, 216(3):317-327.
  • 4Barki-Harrington L, Rockman HA. Beta-arrestins: multifunctional cellular mediators[J]. Physiology (Bethesda), 2008, 23(1) : 17-22.
  • 5Lefkowitz RJ, Shenoy SK. Transduction receptor signals by beta-arrestins[J]. Science, 2005, 308(5721): 512-517.
  • 6Rosano L, Cianfrocca R, Masi S, et al. Beta-arrestins links endothelin A receptor to beta-catenin signaling to induce ovarian cancer cell invasion and metastasis[J]. Proc Natl Acad Sci USA, 2009, 106(8) : 2806-2811.
  • 7Buchanan FG, Gorden DL, Matta P, et al. Role of beta-arrestinl in the metastatic progression of colorectal caucer[]]. Proc Natl Acad Sci U S A, 2006, 103(5): 1492-1497.
  • 8Girnita L, Shenoy SK, Sehat B, et al. Beta-arresfin and Mdm2 mediate IGF-1 receptor-stimulated ERK activation and cell cycle progression[J]. J Biol Chem, 2007, 282(15): 11329-11338.
  • 9Zou L, Yang R, Chai J, et al. Rapid xenograft tumor progression in beta-arrestinl transgenic mice due to enhanced tumor angiogenesis [J]. FASEB J, 2008, 22(2): 355-364.
  • 10陈加力.白血病的MICM分型[J].中华临床医药杂志(北京),2003,4(23):63-64. 被引量:2

共引文献2

同被引文献8

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部